Astex Pharmaceuticals, Inc. (US)
Aram Oganesian, PhD, DABT has extensive experience in Clinical Pharmacology & Nonclinical Development, currently serving as Vice President at Taiho Oncology, Inc. Aram previously held leadership positions at Astex Pharmaceuticals (US) and Pfizer. Oganesian obtained a PhD in Toxicology from Oregon State University and an MS in Biology from Lomonosov Moscow State University.
Astex Pharmaceuticals, Inc. (US)
Astex Pharmaceuticals, Inc. (“Astex”) is committed to the fight against cancer. Astex is developing a proprietary pipeline of novel therapies for the treatment of solid tumors and hematological malignancies. Astex is a member of the Otsuka group of pharmaceutical companies. The group also includes Otsuka Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd and Taiho Oncology, Inc. Subject to regulatory approvals, Astex's products will be commercialized in the US and Canada by Taiho subsidiaries, and the rest of the world by Otsuka subsidiaries.